| Dr Daisy Florence Lazarous, MD | |
|
3800 Reservoir Rd Nw, Washington, DC 20007-2113 | |
| (202) 444-8843 | |
| Not Available |
| Full Name | Dr Daisy Florence Lazarous |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 40 Years |
| Location | 3800 Reservoir Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952397382 | NPI | - | NPPES |
| 21735658001 | Other | OK | BCBS-ALTUS |
| 5683526 | Other | OK | AETNA |
| 1597591 | Other | MD | AETNA HMO |
| 200033150A | Medicaid | OK | |
| 243421103 | Other | MD | MEDICARE RAILROAD |
| 5683526 | Other | MD | AETNA PPO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 23871 (Oklahoma) | Primary |
| 207UN0901X | Nuclear Medicine - Nuclear Cardiology | 23871 (Oklahoma) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
| University Of Md Charles Regional Medical Center | La plata, MD | Hospital |
| Holy Cross Germantown Hospital | Germantown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Physician Services Inc | 4284631540 | 123 |
News Archive
A breakthrough in drug testing developed by a University of Huddersfield lecturer could lead to cheaper, more effective medicines. Dr Hamid Merchant is a member of the team that has created a device which accurately simulates the gastro-intestinal tract and how it absorbs medication.
About one-fifth of commercial sex workers surveyed in Dublin, Ireland, are HIV-positive, while 78% of the surveyed group is living with hepatitis C, according to a report released Tuesday by the National Advisory Committee on Drugs, the Irish Times reports.
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
Aspirin can significantly reduce death rates for postmenopausal women with cardiovascular disease (CVD), researchers reported at the American Heart Association's Scientific Sessions 2005.
› Verified 7 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
A breakthrough in drug testing developed by a University of Huddersfield lecturer could lead to cheaper, more effective medicines. Dr Hamid Merchant is a member of the team that has created a device which accurately simulates the gastro-intestinal tract and how it absorbs medication.
About one-fifth of commercial sex workers surveyed in Dublin, Ireland, are HIV-positive, while 78% of the surveyed group is living with hepatitis C, according to a report released Tuesday by the National Advisory Committee on Drugs, the Irish Times reports.
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
Aspirin can significantly reduce death rates for postmenopausal women with cardiovascular disease (CVD), researchers reported at the American Heart Association's Scientific Sessions 2005.
› Verified 7 days ago
| Entity Name | Adventist Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122 |
News Archive
A breakthrough in drug testing developed by a University of Huddersfield lecturer could lead to cheaper, more effective medicines. Dr Hamid Merchant is a member of the team that has created a device which accurately simulates the gastro-intestinal tract and how it absorbs medication.
About one-fifth of commercial sex workers surveyed in Dublin, Ireland, are HIV-positive, while 78% of the surveyed group is living with hepatitis C, according to a report released Tuesday by the National Advisory Committee on Drugs, the Irish Times reports.
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
Aspirin can significantly reduce death rates for postmenopausal women with cardiovascular disease (CVD), researchers reported at the American Heart Association's Scientific Sessions 2005.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daisy Florence Lazarous, MD Po Box 418283, Boston, MA 02241-8283 Ph: (703) 558-1544 | Dr Daisy Florence Lazarous, MD 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (202) 444-8843 |
News Archive
A breakthrough in drug testing developed by a University of Huddersfield lecturer could lead to cheaper, more effective medicines. Dr Hamid Merchant is a member of the team that has created a device which accurately simulates the gastro-intestinal tract and how it absorbs medication.
About one-fifth of commercial sex workers surveyed in Dublin, Ireland, are HIV-positive, while 78% of the surveyed group is living with hepatitis C, according to a report released Tuesday by the National Advisory Committee on Drugs, the Irish Times reports.
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
Aspirin can significantly reduce death rates for postmenopausal women with cardiovascular disease (CVD), researchers reported at the American Heart Association's Scientific Sessions 2005.
› Verified 7 days ago
Dr. Adefolaju Oketokun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |